Skip to content
The Policy VaultThe Policy Vault

Mavyret — Medica

Genotype 1, 4, 5, or 6 recurrent hepatitis C virus post‑liver transplantation – new start, adult (age ≥ 18 years)

Preferred products

  • Harvoni

Initial criteria

  • Patient has met the Hepatitis C – Mavyret PA for PSM Policy criteria AND
  • Patient has completed a course of Harvoni (brand or generic) with documentation of failure to achieve SVR 12 weeks post‑therapy

Approval duration

as specified in the Hepatitis C – Mavyret PA for PSM Policy